Quarterly report · Q1

Period2023-12-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥13.4bn2023-12-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-12-01 → 2023-11-30Cons.Net sales (5-year summary)
Revenue¥12.8bn2022-12-01 → 2023-02-28Cons.Net sales
Operating income¥454m2023-12-01 → 2024-02-29Cons.Operating income
Operating income−¥93m2022-12-01 → 2023-02-28Cons.Operating income
Ordinary income¥480m2023-12-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-12-01 → 2023-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income−¥64m2022-12-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥393m2023-12-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥86m2022-12-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥249m2023-12-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.2bn2022-12-01 → 2023-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥207m2022-12-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥249m2023-12-01 → 2024-02-29Cons.Profit loss
Net income−¥208m2022-12-01 → 2023-02-28Cons.Profit loss
Total assets¥65.9bnat 2024-02-29Cons.Assets
Total assets¥67.3bnat 2023-11-30Cons.Assets
Total assets¥63.6bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥37.2bnat 2024-02-29Cons.Liabilities
Total liabilities¥38.7bnat 2023-11-30Cons.Liabilities
Net assets / equity¥28.7bnat 2024-02-29Cons.Net assets
Net assets / equity¥28.6bnat 2023-11-30Cons.Net assets
Net assets / equity¥26.5bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥6.9bnat 2023-11-30Cons.Cash and deposits
EPS (basic)¥6.322023-12-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.472022-12-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-5.252022-12-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
Equity ratio43.3%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio42.3%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.5%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 61
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-12-01 → 2024-02-29¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-12-01 → 2024-02-29−¥31m
Reconciling Itemsreconcilingrevenue2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingrevenue intersegment2023-12-01 → 2024-02-29−¥505m
Reconciling Itemsreconcilingsegment profit2023-12-01 → 2024-02-29¥22m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥5.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥5.5bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥371m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥76m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2023-12-01 → 2024-02-29¥3.0bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥14m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2023-12-01 → 2024-02-29¥93m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥20m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2023-12-01 → 2024-02-29¥112m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2023-12-01 → 2024-02-29¥2.5bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2023-12-01 → 2024-02-29¥2.4bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2023-12-01 → 2024-02-29¥100m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2023-12-01 → 2024-02-29¥182m
—segment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
—segment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
—segment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
—segment totalsegment profit2023-12-01 → 2024-02-29¥463m
Total Of Reportable Segments And Otherssegment totalrevenue2023-12-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-12-01 → 2024-02-29¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-12-01 → 2024-02-29¥505m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-12-01 → 2024-02-29¥432m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-12-01 → 2023-02-28¥1m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-12-01 → 2023-02-28¥55,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-12-01 → 2023-02-28−¥23m
Reconciling Itemsreconcilingrevenue2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingrevenue intersegment2022-12-01 → 2023-02-28−¥429m
Reconciling Itemsreconcilingsegment profit2022-12-01 → 2023-02-28¥60m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥4.9bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.6bn
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥341m
jpcrp040300-q1r_E02585-000Fine Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28¥26m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue external2022-12-01 → 2023-02-28¥4.2bn
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥10m
jpcrp040300-q1r_E02585-000Health And Beauty Care Foodreportable segmentsegment profit2022-12-01 → 2023-02-28−¥42m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥17m
jpcrp040300-q1r_E02585-000Industrial Chemicalsreportable segmentsegment profit2022-12-01 → 2023-02-28−¥105m
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue external2022-12-01 → 2023-02-28¥2.0bn
jpcrp040300-q1r_E02585-000Medicalreportable segmentrevenue intersegment2022-12-01 → 2023-02-28¥61m
jpcrp040300-q1r_E02585-000Medicalreportable segmentsegment profit2022-12-01 → 2023-02-28−¥9m
—segment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
—segment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
—segment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
—segment totalsegment profit2022-12-01 → 2023-02-28−¥130m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-02-28¥13.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-02-28¥12.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-12-01 → 2023-02-28¥429m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-02-28−¥153m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 447
ItemContextValueUnit
Income taxesCurrentYTDDuration144294000JPY
Profit lossPrior1YTDDuration-208420000JPY
Profit lossCurrentYTDDuration248801000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-1625000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-631000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-206794000JPY
Profit loss attributable to owners of parentCurrentYTDDuration249432000JPY
Profit lossPrior1YTDDuration-208420000JPY
Profit lossCurrentYTDDuration248801000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration21572000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration227823000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration4869000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration684000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration14139000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration3795000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-54300000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-8628000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration274000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration87000JPY
Other comprehensive incomePrior1YTDDuration-13444000JPY
Other comprehensive incomeCurrentYTDDuration223762000JPY
Comprehensive incomePrior1YTDDuration-221864000JPY
Comprehensive incomeCurrentYTDDuration472564000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-220239000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration473195000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-1625000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-631000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember4570227000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember4218501000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember1981598000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember2013797000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember12784124000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1317000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember12785442000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration12785442000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember341330000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember9712000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember60834000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember17343000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember429221000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember55000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember429276000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-429276000JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02585-000FineChemicalsReportableSegmentsMember4911557000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember4228214000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02585-000MedicalReportableSegmentsMember2042433000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E02585-000IndustrialChemicalsReportableSegmentsMember2031141000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember13213346000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-11-30pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-12-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-12-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-12-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-11-30pass
statement vs summary · total assetsconsolidated 2024-02-29pass